As of 2024-07-27, the Relative Valuation of Neogenomics Inc (NEO) is (24.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.88 USD, the upside of Neogenomics Inc based on Relative Valuation is -264.2%.
The range of the Relative Valuation is (23.70) - (23.59) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.0x - 42.4x | 39.1x |
| Forward P/E multiples | 34.3x - 35.8x | 35.0x |
| Fair Price | (23.70) - (23.59) | (24.44) |
| Upside | -259.3% - -258.5% | -264.2% |
| Date | P/E |
| 2024-07-26 | -22.57 |
| 2024-07-25 | -22.88 |
| 2024-07-24 | -23.03 |
| 2024-07-23 | -22.65 |
| 2024-07-22 | -22.45 |
| 2024-07-19 | -22.01 |
| 2024-07-18 | -22.36 |
| 2024-07-17 | -23.51 |
| 2024-07-16 | -24.03 |
| 2024-07-15 | -22.50 |
| 2024-07-12 | -22.44 |
| 2024-07-11 | -21.77 |
| 2024-07-10 | -20.51 |
| 2024-07-09 | -20.33 |
| 2024-07-08 | -20.80 |
| 2024-07-05 | -20.60 |
| 2024-07-03 | -20.83 |
| 2024-07-02 | -20.83 |
| 2024-07-01 | -21.13 |
| 2024-06-28 | -21.04 |
| 2024-06-27 | -20.24 |
| 2024-06-26 | -20.15 |
| 2024-06-25 | -19.84 |
| 2024-06-24 | -19.98 |
| 2024-06-21 | -19.98 |
| 2024-06-20 | -19.74 |
| 2024-06-18 | -19.74 |
| 2024-06-17 | -19.87 |
| 2024-06-14 | -19.99 |
| 2024-06-13 | -20.36 |
| 2024-06-12 | -21.33 |
| 2024-06-11 | -19.96 |
| 2024-06-10 | -20.21 |
| 2024-06-07 | -19.74 |
| 2024-06-06 | -19.92 |
| 2024-06-05 | -20.40 |
| 2024-06-04 | -20.18 |
| 2024-06-03 | -20.51 |
| 2024-05-31 | -20.80 |
| 2024-05-30 | -21.24 |
| 2024-05-29 | -20.98 |
| 2024-05-28 | -21.43 |
| 2024-05-24 | -21.60 |
| 2024-05-23 | -21.07 |
| 2024-05-22 | -21.91 |
| 2024-05-21 | -22.42 |
| 2024-05-20 | -22.62 |
| 2024-05-17 | -22.45 |
| 2024-05-16 | -22.74 |
| 2024-05-15 | -22.95 |